FDA Inspection 1088851 — Tatjana A. Pejcic, MD PhD
The FDA completed an inspection of Tatjana A. Pejcic, MD PhD on April 18, 2019 in Nis. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nis (Serbia)
Additional Details
Clinical Investigator (CI)